Is hemi-thyroidectomy adequate in low risk differentiated thyroid cancer?

Is hemi-thyroidectomy adequate in low risk differentiated thyroid cancer?

Show other versions (1)

In low-risk differentiated thyroid carcinoma (LRDTC), appropriate surgical procedure in terms of hemi/total thyroidectomy (TT) has been an area of debate. The aim was to determine whether in LRDTC patients, hemithyroidectomy would be an adequate treatment, determine incidence of disease in contralat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Justin Benjamin, Julie Hephzibah, Anish Jacob Cherian, David Mathew, Nylla Shanthly, Regi Oommen
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2019-04-01
Series:	World Journal of Nuclear Medicine
Subjects:	hemithyroidectomy low-risk differentiated thyroid carcinoma radioactive iodine ablation stimulated thyroglobulin
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.4103/wjnm.wjnm_70_18
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Is hemi-thyroidectomy adequate in low risk differentiated thyroid cancer?
by: Justin Benjamin, et al.
Published: (2019-01-01)

Thyroidectomy, especially total thyroidectomy, adversely affects erectile function in men
by: Yushu Huang, et al.
Published: (2025-03-01)

Association between serum thyroglobulin levels and glycemic control in patients with thyroid cancer after radioiodine therapy
by: Yuji Hataya, et al.
Published: (2025-05-01)

Pilot study of ultrasound-guided microwave ablation for inactivating excess remnant thyroid after surgery in patients with differentiated thyroid cancer
by: Yihao Chen, et al.
Published: (2025-03-01)

Impact of extent thyroidectomy and radioactive iodine ablation for disease free survival in the intermediate-risk patients with lateral neck lymph node metastasis: a retrospective and tentative real-world approach
by: Kiyomi Horiuchi, et al.
Published: (2025-07-01)

Retrospective comparison of individual risk factors hemithyroidectomy and thyroidectomy in patients with papillary carcinoma of the thyroid gland in combination with autoimmune thyroiditis
by: E. V. Ryabchenko
Published: (2023-03-01)

Follow-up and transition of care for low recurrence risk thyroid cancer patients in Canada
by: Ralf Paschke, et al.
Published: (2025-06-01)

POSTRADIAL SIALOZOADENITIS IN PATIENTS WITH PAPILLARY CARCINOMA OF THE THYROID GLAND
by: V. A. Kovalenko, et al.
Published: (2015-02-01)

Perception of health and illness and quality of life after total thyroidectomy for differentiated thyroid carcinoma: the PERSAM study
by: Elena Groff, et al.
Published: (2024-12-01)

Second Adjuvant Radioiodine Therapy after Reoperation for Locoregionally Persistent or Recurrent Papillary Thyroid Carcinoma
by: Enrique Cadena-Piñeros, et al.
Published: (2022-12-01)

Development of an enzyme-linked immunosorbent assay for newborns dried blood spot thyroglobulin
by: Camilo Fuentes Peña, et al.
Published: (2024-11-01)

Risk factors and clinical characteristics associated with post-radioactive iodine thyroid storm
by: Harold Henrison C. Chiu, et al.
Published: (2024-12-01)

Clinical predictors of I-131 therapy failure in differentiated thyroid cancer by machine learning: A single-center experience
by: David J. Lubin, et al.
Published: (2021-07-01)

ANTI-THYROGLOBULIN ANTIBODIES IN PATIENTS WITH AUTOIMMUNE THYROIDITIS DURING L-THYROXINE TREATMENT
by: O. A. Shashkova, et al.
Published: (2014-07-01)

Value of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in staging of patients with differentiated thyroid cancer after thyroidectomy during the first course of radioiodine therapy
by: T. M. Geliashvili, et al.
Published: (2021-01-01)

The assessment of radio-adaptive response in graves' hyperthyroidism patients following radioactive iodine uptake
by: Zahra Fazeli, et al.
Published: (2018-10-01)

Antithyroglobulin antibody as a marker of successful ablation therapy in differentiated thyroid cancer
by: Ayu Dewi, et al.
Published: (2017-01-01)

STRUCTURAL AND FUNCTIONAL DISORDERS OF THE THYROID GLAND IN DIFFERENT TYPES OF LARYNGEAL CANCER TREATMENT
by: I. N. Vorozhtsova, et al.
Published: (2014-04-01)

Radioactive 131Iodine body burden and blood dose estimates in treatment for differentiated thyroid cancer by external probe counting
by: Ramamoorthy Ravichandran, et al.
Published: (2016-07-01)

Comparing antithyroid drugs vs. radioactive iodine in paediatric Graves’ disease: literature review
by: Akshat Sinha, et al.
Published: (2025-05-01)

REFRACTORY OF WELL-DIFFERENTIATED THYROID CANCER TO THE TREATMENT WITH RADIOACTIVE IODINE
by: P. O. Rumyantsev
Published: (2015-04-01)

Applicability of Adults 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines for Postoperative Risk Stratification and Postradioiodine Treatment Dynamic Risk Stratification in Pediatric Population
by: Shashank Shekhar Singh, et al.
Published: (2022-06-01)

COURSE OF PAPILLARY THYROID CARCINOMA DIAGNOSED IN CHILDHOOD AND ADOLESCENCE AND FOLLOWED THROUGH ADULTHOOD: EXPERIENCE FROM A TERTIARY REFERRAL CENTER
by: Hülya Hacışahinoğulları, et al.
Published: (2023-10-01)

Dynamics of free radicals processes in rat blood with partially blocked thyroid gland by stable iodine
by: Yu. P. Grynevych, et al.
Published: (2016-12-01)

Clinical experience in using lenvatinib in patients with progressive, radioactive iodine-refractory differentiated thyroid cancer
by: P. A. Isaev, et al.
Published: (2016-06-01)

Pediatric differentiated thyroid carcinoma leading to fatal lung fibrosis
by: Michaela Kuhlen, et al.
Published: (2025-02-01)

The effect of retinoic acid in the ability of cold solid thyroid nodule to take up radioactive iodine: A preliminary study
by: Andreas Lim, et al.
Published: (2019-07-01)

Long-term outcomes after a radioactive iodine treatment for a single autonomous functioning thyroid nodule in Japan
by: Ai Yoshihara, et al.
Published: (2025-05-01)

LENVATINIB IN TREATMENT OF RADIOACTIVE IODINE-REFRACTORY WELL-DIFFERENTIATED THYROID CARCINOMA
by: I. S. Romanov, et al.
Published: (2017-06-01)

Thyroglobulin-to-tumor volume ratio combined with ultrasound features for diagnosing thyroid follicular neoplasms
by: Xixi Zhu, et al.
Published: (2025-07-01)

2025 Korean Thyroid Association Management Guidelines for Radioactive Iodine Therapy in Patients with Hyperthyroidism
by: Kyeong Jin Kim, et al.
Published: (2025-06-01)

Clinical efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in thyroglobulin-elevated negative iodine scintigraphy: A “not-so-promising” result compared to GEP-NETs
by: Sandip Basu, et al.
Published: (2020-07-01)

Diagnostic Value of Stimulated Serum Thyroglobulin in the Follow-up of Patients with Differentiated Thyroid Cancer
by: Vlado Wagenhofer, et al.
Published: (2024-01-01)

Visualization Analysis of Research Hotspots and Trends in Treatment of Radioactive Iodine Refractory Differentiated Thyroid Carcinoma
by: Xiaoxian ZENG, et al.
Published: (2025-02-01)

The incidence of hypothyroidism following the radioactive iodine treatment of graves' disease and the predictive factors influencing its development
by: Maha Husseni
Published: (2016-01-01)

The impact of natural removal on the release of nuclides into the containment after accident
by: Haiying Chen, et al.
Published: (2025-03-01)

Impact of positive lymph nodes and RAI therapy on survival in N1b papillary thyroid carcinoma
by: Jie Jian, et al.
Published: (2025-05-01)

Risk-adapted therapy in pediatric thyroid cancer: initial experience from a national reference program by the MET group
by: Michaela Kuhlen, et al.
Published: (2025-08-01)

Adjuvant treatments for locally advanced differentiated thyroid cancer: a nationwide survey in Japan
by: Terufumi Kawamoto, et al.
Published: (2023-10-01)

Efficacy and safety of anlotinib combined with 125I seed implantation for iodine-refractory thyroid cancer
by: Zhijun Chen, et al.
Published: (2025-08-01)